Advertisement

Topics

FDA orphan status given to Revive's ischemia, reperfusion injury drug

04:54 EST 9 Nov 2018 | SmartBrief

Orphan drug status was granted by the FDA to Revive Therapeutics' cannabidiol, which is being developed for the prevention of -More

Original Article: FDA orphan status given to Revive's ischemia, reperfusion injury drug

NEXT ARTICLE

More From BioPortfolio on "FDA orphan status given to Revive's ischemia, reperfusion injury drug"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...